Metraipolis › archive › dc_03dee77a09fa

A Predictive Immunological Signature Associated with Pathological Response in Breast Cancer Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:41898309

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898309
DOI
10.3390/biomedicines14030663
License (as archived)
solo-consultazione
Archived
2026-11-04T09:34:41.142Z
SHA-256 of the archived text
8caef3a833b3b5125b51afaa4a9471042d1bcff805e40560a1c92bcd48003470
Stable URL of this page
https://metraipolis.com/documento/dc_03dee77a09fa

How to cite

A Predictive Immunological Signature Associated with Pathological Response in Breast Cancer Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:41898309 — Europe PMC (en), https://europepmc.org/article/MED/41898309 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03dee77a09fa (Metraipolis archive dc_03dee77a09fa, sha256 8caef3a833b3b5125b51afaa4a9471042d1bcff805e40560a1c92bcd48003470)
BibTeX
@misc{dc03dee77a09fa,
  title = {A Predictive Immunological Signature Associated with Pathological Response in Breast Cancer Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:41898309},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898309},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03dee77a09fa; sha256 8caef3a833b3b5125b51afaa4a9471042d1bcff805e40560a1c92bcd48003470},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898309. Agents can read the archived copy with the MCP tool read_document.